Cardiovascular and Renal Outcomes with Finerenone, a Selective Mineralocorticoid Receptor Antagonist

Overactivation of the renin–angiotensin–aldosterone system (RAAS) has been shown to be pathologic in heart failure and albuminuric chronic kidney disease (CKD), triggering pro-inflammatory and pro-fibrotic cellular pathways. The standard of care in these disease states includes treatment with angiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Palanisamy, Srikanth, Funes Hernandez, Mario, Chang, Tara I., Mahaffey, Kenneth W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381668/
https://www.ncbi.nlm.nih.gov/pubmed/35737275
http://dx.doi.org/10.1007/s40119-022-00269-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381668/
https://www.ncbi.nlm.nih.gov/pubmed/35737275
http://dx.doi.org/10.1007/s40119-022-00269-3

Ejemplares similares